Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Source
Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, et al. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. N Engl J Med. 2025;392(14):1396-1405. doi:10.1056/NEJMoa2500366
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
DapaTAVI Trial analyzed the benefits of dapagliflozin treatment in patients with severe aortic stenosis discharged after transcatheter aortic-valve implantation (TAVI).
User Segments
Release Date
Featured Order
0
Is Paid
0